Please ensure Javascript is enabled for purposes of website accessibility

Teladoc Health Upsizes, Prices Convertible Notes Issue

By Eric Volkman – May 17, 2020 at 10:07AM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The issue should bring in around $829 million for the telehealth company.

Teladoc Health (TDOC -3.54%) stands to reap tens of millions of dollars more than it initially planned from an upcoming convertible senior notes issue. The company announced Friday that it has upsized its flotation of such securities to $850 million, from the previous goal of $800 million.

It also set the annual interest rate of the notes, which will be 1.25%. Interest is to be paid on June 1 and Dec. 1 of every year. The notes convert to 4.1258 common shares of the company per $1,000 principal amount, equating to around $242.38 per share; that's well above the latest closing stock price of $184.23. The company has the right to settle conversions either entirely in stock, or in a mix of shares and cash.

Piggy bank with stethoscope.

Image source: Getty Images.

As Teladoc stated when it initially announced the issue last week, the notes from the upcoming issue will mature on June 1, 2027 if not converted, redeemed, or purchased. It can redeem the notes starting on June 5, 2024, under certain conditions.

After fees and expenses related to the flotation are deducted, Teladoc estimates that it will bring in net proceeds of $829 million for the company. These funds are to be used to retire an existing convertible senior notes issue that matures next year (and is more expensive, with a 3% interest rate); this will be effected with a mix of the cash and shares of the company's common stock.

Teladoc will also utilize the money for "working capital and other general corporate purposes, including the repayment of certain indebtedness."

The healthcare company said the notes issue is slated to close on Tuesday, May 19.  

On Friday, Teladoc shares closed 2.6% higher, beating the gains of the major equities market indexes.

Eric Volkman has no position in any of the stocks mentioned. The Motley Fool owns shares of and recommends Teladoc Health. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Teladoc Health, Inc. Stock Quote
Teladoc Health, Inc.
TDOC
$26.97 (-3.54%) $0.99

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
329%
 
S&P 500 Returns
106%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 09/24/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.